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Background
In tuberculosis vaccine studies, perfingolysin expressing
strains (pfo) of recombinant Mycobacterium bovis
(rBCG) have been shown to enhance immunogenicity as
compared to wildtype strains whilst pantothenate auxo-
trophic strains (ΔpanCD) have been shown to be safer
and more immunogenic. Our group has recently shown
that rBCGΔpanCD expressing HIV-1 Gag is more immu-
nogenic than the wildtype Pasteur strain of BCG in the
murine model. In this study, a wild type strain, a
ΔpanCDstrain, a pfo strain and a ΔpanCD strain expres-
sing perfringolysin (ΔpanCDpfo) of Danish BCG were
used as vectors to express HIV-1 subtype C Gag. Gag
specific immune responses induced by a prime with each
rBCG-Gag vaccine and boost with modified vaccinia
Ankara (MVA) were compared.
Methods
rBCG vaccines were given intraperitoneally to BALB/c
mice followed by an intramuscular MVA boost after 28
days. Twelve days after the boost, mice were sacrificed
and single cell suspensions of splenocytes were stimu-
lated with HIV peptides. Immunogenicity was assessed
using an IFN-g ELISPOT assay, cytokine bead array and
multi-parameter flow cytometry.
Results
All the rBCG-Gag vaccines primed the immune
response to a boost with MVA. Cytokine kinetic mea-
surements and flow cytometry indicated a more rapid
and robust release of pro-inflammatory cytokines, in
response to ex vivo HIV peptides, from the splenocytes
of mice vaccinated with rBCGΔpanCD(gag) as compared
to rBCGpfo(gag)(p<0.001- p<0.05) and rBCG(gag)
(p<0.01- p<0.05). A rBCGΔpanCD(gag) prime induced
increased polyfunctional HIV specific CD4+ and CD8+
T cells as compared to the other strains of BCG. We
observed no enhancement of immunogenicity in the
rBCGΔpanCDpfo(gag) group as compared to the
rBCGΔpanCD(gag) group.
Conclusion
As this study indicated the Danish ΔpanCD vector
induced a more robust and rapid Gag-specific immune
response than the wild type and perfringolysin expres-
sing BCG Danish vectors, the Danish ΔpanCD vector
maybe an attractive option for HIV vaccines.
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